Plasma ctDNA is a tumor tissue surrogate and enables clinical-genomic stratification of metastatic bladder cancer

Molecular stratification can improve the management of advanced cancers, but requires relevant tumor samples. Metastatic urothelial carcinoma (mUC) is poised to benefit given a recent expansion of treatment options and its high genomic heterogeneity. We profile minimally-invasive plasma circulating...

Descripción completa

Detalles Bibliográficos
Autores principales: Vandekerkhove, Gillian, Lavoie, Jean-Michel, Annala, Matti, Murtha, Andrew J., Sundahl, Nora, Walz, Simon, Sano, Takeshi, Taavitsainen, Sinja, Ritch, Elie, Fazli, Ladan, Hurtado-Coll, Antonio, Wang, Gang, Nykter, Matti, Black, Peter C., Todenhöfer, Tilman, Ost, Piet, Gibb, Ewan A., Chi, Kim N., Eigl, Bernhard J., Wyatt, Alexander W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794518/
https://www.ncbi.nlm.nih.gov/pubmed/33420073
http://dx.doi.org/10.1038/s41467-020-20493-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794518/
https://www.ncbi.nlm.nih.gov/pubmed/33420073
http://dx.doi.org/10.1038/s41467-020-20493-6

Ejemplares similares